WASHINGTON — Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), the bipartisan duo behind the Senate’s leading drug pricing proposal, both accused Senate Majority Leader Mitch McConnell of sabotaging their progress on that package Wednesday.

The remarks are especially surprising from Grassley, one of the Senate’s highest-ranking Republicans.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Wow, now the power brokers of republicans in the senate are fighting each other. I believe it is because McConnell thinks he is the US king.

  • All corrupt crooks and blood suckers, and anyone with unscrupulous big pockets like those in the article above : come to America – you’ll feel welcome here, in the massively corruptable state of our nation !

  • The CEOs of Abbvie, Bristol-Myers Squibb, Merck, Pfizer, Roche Pharmaceuticals, and Sanofi each contributed $15,600 to McConnell’s joint fundraising committee in the third quarter. Novo Nordisk Executive Vice President Doug Langa chipped in $10,000, Amgen CEO Robert Bradway gave $7,500, and Celgene CEO Mark Alles contributed $5,000.

Your daily dose of news in health and medicine

Privacy Policy